ANN for Parkinson’s Disease Prediction

Parkinson's Disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Doctors do not know what causes it and finds difficulty in early diagnosing the presence of Parkinson’s disease. An artificial neural network system with back propagation algorithm is presented in this paper for helping doctors in identifying PD. Previous research with regards to predict the presence of the PD has shown accuracy rates up to 93% [1]; however, accuracy of prediction for small classes is reduced. The proposed design of the neural network system causes a significant increase of robustness. It is also has shown that networks recognition rates reached 100%

Wearable Platform for Automatic Recognition of Parkinson Disease by Muscular Implication Monitoring

The need for diagnostic tools for the characterization of progressive movement disorders - as the Parkinson Disease (PD) - aiming to early detect and monitor the pathology is getting more and more impelling. The parallel request of wearable and wireless solutions, for the real-time monitoring in a non-controlled environment, has led to the implementation of a Quantitative Gait Analysis platform for the extraction of muscular implications features in ordinary motor action, such as gait. The here proposed platform is used for the quantification of PD symptoms. Addressing the wearable trend, the proposed architecture is able to define the real-time modulation of the muscular indexes by using 8 EMG wireless nodes positioned on lower limbs. The implemented system “translates” the acquisition in a 1-bit signal, exploiting a dynamic thresholding algorithm. The resulting 1-bit signals are used both to define muscular indexes both to drastically reduce the amount of data to be analyzed, preserving at the same time the muscular information. The overall architecture has been fully implemented on Altera Cyclone V FPGA. The system has been tested on 4 subjects: 2 affected by PD and 2 healthy subjects (control group). The experimental results highlight the validity of the proposed solution in Disease recognition and the outcomes match the clinical literature results

Longitudinal clustering analysis and prediction of Parkinson\u27s disease progression using radiomics and hybrid machine learning

Background: We employed machine learning approaches to (I) determine distinct progression trajectories in Parkinson\u27s disease (PD) (unsupervised clustering task), and (II) predict progression trajectories (supervised prediction task), from early (years 0 and 1) data, making use of clinical and imaging features. Methods: We studied PD-subjects derived from longitudinal datasets (years 0, 1, 2 & 4; Parkinson\u27s Progressive Marker Initiative). We extracted and analyzed 981 features, including motor, non-motor, and radiomics features extracted for each region-of-interest (ROIs: left/right caudate and putamen) using our standardized standardized environment for radiomics analysis (SERA) radiomics software. Segmentation of ROIs on dopamine transposer - single photon emission computed tomography (DAT SPECT) images were performed via magnetic resonance images (MRI). After performing cross-sectional clustering on 885 subjects (original dataset) to identify disease subtypes, we identified optimal longitudinal trajectories using hybrid machine learning systems (HMLS), including principal component analysis (PCA) + K-Means algorithms (KMA) followed by Bayesian information criterion (BIC), Calinski-Harabatz criterion (CHC), and elbow criterion (EC). Subsequently, prediction of the identified trajectories from early year data was performed using multiple HMLSs including 16 Dimension Reduction Algorithms (DRA) and 10 classification algorithms. Results: We identified 3 distinct progression trajectories. Hotelling\u27s t squared test (HTST) showed that the identified trajectories were distinct. The trajectories included those with (I, II) disease escalation (2 trajectories, 27% and 38% of patients) and (III) stable disease (1 trajectory, 35% of patients). For trajectory prediction from early year data, HMLSs including the stochastic neighbor embedding algorithm (SNEA, as a DRA) as well as locally linear embedding algorithm (LLEA, as a DRA), linked with the new probabilistic neural network classifier (NPNNC, as a classifier), resulted in accuracies of 78.4% and 79.2% respectively, while other HMLSs such as SNEA + Lib_SVM (library for support vector machines) and t_SNE (t-distributed stochastic neighbor embedding) + NPNNC resulted in 76.5% and 76.1% respectively. Conclusions: This study moves beyond cross-sectional PD subtyping to clustering of longitudinal disease trajectories. We conclude that combining medical information with SPECT-based radiomics features, and optimal utilization of HMLSs, can identify distinct disease trajectories in PD patients, and enable effective prediction of disease trajectories from early year data

Diagnosis of Parkinson's Disease Based on Voice Signals Using SHAP and Hard Voting Ensemble Method

Background and Objective: Parkinson's disease (PD) is the second most common progressive neurological condition after Alzheimer's, characterized by motor and non-motor symptoms. Developing a method to diagnose the condition in its beginning phases is essential because of the significant number of individuals afflicting with this illness. PD is typically identified using motor symptoms or other Neuroimaging techniques, such as DATSCAN and SPECT. These methods are expensive, time-consuming, and unavailable to the general public; furthermore, they are not very accurate. These constraints encouraged us to develop a novel technique using SHAP and Hard Voting Ensemble Method based on voice signals. Methods: In this article, we used Pearson Correlation Coefficients to understand the relationship between input features and the output, and finally, input features with high correlation were selected. These selected features were classified by the Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), Gradient Boosting, and Bagging. Moreover, the Hard Voting Ensemble Method was determined based on the performance of the four classifiers. At the final stage, we proposed Shapley Additive exPlanations (SHAP) to rank the features according to their significance in diagnosing Parkinson's disease. Results and Conclusion: The proposed method achieved 85.42% accuracy, 84.94% F1-score, 86.77% precision, 87.62% specificity, and 83.20% sensitivity. The study's findings demonstrated that the proposed method outperformed state-of-the-art approaches and can assist physicians in diagnosing Parkinson's cases

Non-linear mapping for exploratory data analysis in functional genomics

BACKGROUND: Several supervised and unsupervised learning tools are available to classify functional genomics data. However, relatively less attention has been given to exploratory, visualisation-driven approaches. Such approaches should satisfy the following factors: Support for intuitive cluster visualisation, user-friendly and robust application, computational efficiency and generation of biologically meaningful outcomes. This research assesses a relaxation method for non-linear mapping that addresses these concerns. Its applications to gene expression and protein-protein interaction data analyses are investigated RESULTS: Publicly available expression data originating from leukaemia, round blue-cell tumours and Parkinson disease studies were analysed. The method distinguished relevant clusters and critical analysis areas. The system does not require assumptions about the inherent class structure of the data, its mapping process is controlled by only one parameter and the resulting transformations offer intuitive, meaningful visual displays. Comparisons with traditional mapping models are presented. As a way of promoting potential, alternative applications of the methodology presented, an example of exploratory data analysis of interactome networks is illustrated. Data from the C. elegans interactome were analysed. Results suggest that this method might represent an effective solution for detecting key network hubs and for clustering biologically meaningful groups of proteins. CONCLUSION: A relaxation method for non-linear mapping provided the basis for visualisation-driven analyses using different types of data. This study indicates that such a system may represent a user-friendly and robust approach to exploratory data analysis. It may allow users to gain better insights into the underlying data structure, detect potential outliers and assess assumptions about the cluster composition of the data

KOMPLEKSOWE METODY UCZENIA MASZYNOWEGO I UCZENIA GŁĘBOKIEGO DO KLASYFIKACJI CHOROBY PARKINSONA I OCENY JEJ NASILENIA

In this study, we aimed to adopt a comprehensive approach to categorize and assess the severity of Parkinson's disease by leveraging techniques from both machine learning and deep learning. We thoroughly evaluated the effectiveness of various models, including XGBoost, Random Forest, Multi-Layer Perceptron (MLP), and Recurrent Neural Network (RNN), utilizing classification metrics. We generated detailed reports to facilitate a comprehensive comparative analysis of these models. Notably, XGBoost demonstrated the highest precision at 97.4%. Additionally, we took a step further by developing a Gated Recurrent Unit (GRU) model with the purpose of combining predictions from alternative models. We assessed its ability to predict the severity of the ailment. To quantify the precision levels of the models in disease classification, we calculated severity percentages. Furthermore, we created a Receiver Operating Characteristic (ROC) curve for the GRU model, simplifying the evaluation of its capability to distinguish among various severity levels. This comprehensive approach contributes to a more accurate and detailed understanding of Parkinson's disease severity assessment.W tym badaniu naszym celem było przyjęcie kompleksowego podejścia do kategoryzacji i oceny ciężkości choroby Parkinsona poprzez wykorzystanie technik zarówno uczenia maszynowego, jak i głębokiego uczenia. Dokładnie oceniliśmy skuteczność różnych modeli, w tym XGBoost, Random Forest, Multi-Layer Perceptron (MLP) i Recurrent Neural Network (RNN), wykorzystując wskaźniki klasyfikacji. Wygenerowaliśmy szczegółowe raporty, aby ułatwić kompleksową analizę porównawczą tych modeli. Warto zauważyć, że XGBoost wykazał najwyższą precyzję na poziomie 97,4%. Ponadto poszliśmy o krok dalej, opracowując model Gated Recurrent Unit (GRU) w celu połączenia przewidywań z alternatywnych modeli. Oceniliśmy jego zdolność do przewidywania nasilenia dolegliwości. Aby określić ilościowo poziomy dokładności modeli w klasyfikacji chorób, obliczyliśmy wartości procentowe nasilenia. Ponadto stworzyliśmy krzywą charakterystyki operacyjnej odbiornika (ROC) dla modelu GRU, upraszczając ocenę jego zdolności do rozróżniania różnych poziomów nasilenia. To kompleksowe podejście przyczynia się do dokładniejszego i bardziej szczegółowego zrozumienia oceny ciężkości choroby Parkinsona

Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: Actuality and expectations

Idiopathic Parkinson's Disease (iPD) is a common motor neurodegenerative disorder. It affects more frequently the elderly population, causing a significant emotional burden both for the patient and caregivers, due to the disease-related onset of motor and cognitive disabilities. iPD's clinical hallmark is the onset of cardinal motor symptoms such as bradykinesia, rest tremor, rigidity, and postural instability. However, these symptoms appear when the neurodegenerative process is already in an advanced stage. Furthermore, the greatest challenge is to distinguish iPD from other similar neurodegenerative disorders, "atypical parkinsonisms", such as Multisystem Atrophy, Progressive Supranuclear Palsy and Cortical Basal Degeneration, since they share many phenotypic manifestations, especially in the early stages. The diagnosis of these neurodegenerative motor disorders is essentially clinical. Consequently, the diagnostic accuracy mainly depends on the professional knowledge and experience of the physician. Recent advances in artificial intelligence have made it possible to analyze the large amount of clinical and instrumental information in the medical field. The application machine learning algorithms to the analysis of neuroimaging data appear to be a promising tool for identifying microstructural alterations related to the pathological process in order to explain the onset of symptoms and the spread of the neurodegenerative process. In this context, the search for quantitative biomarkers capable of identifying parkinsonian patients in the prodromal phases of the disease, of correctly distinguishing them from atypical parkinsonisms and of predicting clinical evolution and response to therapy represent the main goal of most current clinical research studies. Our aim was to review the recent literature and describe the current knowledge about the contribution given by machine learning applications to research and clinical management of parkinsonian syndromes